Resultados de la búsqueda 341-350 de 3077 para anti-TNF drugs

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... Therapy Treatment for a Brain Tumor. Rochester, Minn. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving nivolumab, ipilimumab, and radiation therapy may kill more cancer cells.

3. Neurología - Ensayos clínicos

   ... drugs in the iPSC-derived muscle cells. A Study to Clarify the Relationship Between Autonomic Nervous System Regulation and Cognitive Performance. Rochester ...

4. Aceite de pescado - Mayo Clinic

   Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Nov. 22, 2020. Omega-3 supplements: In depth. National Center for ...

5. Youtube-Mayo Clinic Minute 2 reasons not to share pain pills

   Vivien Williams: El Dr. Mike Hooten, experto en manejo del dolor de Mayo Clinic, explica dos grandes motivos por los que no debes compartir analgésicos opioides ...

6. Terapia con testosterona: beneficios y riesgos potenciales a medida que envejeces - Mayo Clinic

   Salud sexual. Más información; Testosterone therapy Potential benefits and risks as you age. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo? Para ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as daunorubicin and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells, by ...

8. Lactancia materna y medicamentos: ¿qué es seguro? - Mayo Clinic

   Reaffirmed 2014. Wambach K, et al., eds. Drug therapy and breastfeeding. In: Breastfeeding and Human Lactation. 5th ed. Sudbury, Mass.: Jones and Bartlett ...

9. Neurología - Ensayos clínicos

   ... treatment (including surgery, radiation and/or adjuvant or neoadjuvant chemotherapy). ... drugs in the iPSC-derived muscle cells. Cerebral Spinal Fluid Evaluation ...

10. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.